Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients
Condition(s):Head and Neck CancerLast Updated:September 29, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Head and Neck CancerLast Updated:September 29, 2021Completed
Condition(s):Breast Cancer; Radiation DermatitisLast Updated:January 31, 2024Completed
Condition(s):Dermatitis, Adverse Drug ReactionLast Updated:August 2, 2016Unknown status
Condition(s):Epidermoid Head and Neck CancerLast Updated:August 25, 2014Unknown status
Condition(s):Advanced Lung AdenocarcinomaLast Updated:January 24, 2022Completed
Condition(s):Skin ToxicityLast Updated:March 1, 2023Completed
Condition(s):Breast CancerLast Updated:October 22, 2020Completed
Condition(s):Toxicity Due to RadiotherapyLast Updated:January 27, 2021Completed
Condition(s):Colorectal CancerLast Updated:October 11, 2019Completed
Condition(s):Radiation Dermatitis; Radiation-induced Oral MucositisLast Updated:November 3, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.